Evidence map›Paper›PMID 22698919›Full record

Trial reportDiabetes2012

B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men.

Greisa Vila, Gabriele Grimm, Michael Resl, Birgit Heinisch, Elisa Einwallner, Harald Esterbauer, Benjamin Dieplinger, Thomas Mueller, Anton Luger, Martin Clodi

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01375153 nacompletednot on this map

Effects of Brain Natriuretic Peptide on Appetite-regulating Hormones and Endothelial-derived Peptides

TypeinterventionalSponsorMedical University of ViennaRan2010 to 2011Enrolled10ConditionsHealthyArmsBNP, 0.9% NaCl
NCT03234751 phase1completednot on this mapstarted 2017, after this paper: background citation

Effect of Nesiritide Infusion on Insulin Sensitivity in Healthy Obese Insulin Resistant Subjects

TypeinterventionalSponsorAdventHealth Translational Research InstituteRan2017 to 2020Enrolled6ConditionsDiabetesArmsContinous IV infusion of Nesiritide, Hyperinsulinemic euglycemic clamp, Placebo
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control.Therapeutic advances in endocrinology and metabolism · 2020
    Review
  14. Article
  15. Article
  16. Cardiomyokines from the heart.Cellular and molecular life sciences : CMLS · 2018
    Review
  17. Article
  18. The multifaceted role of natriuretic peptides in metabolic syndrome.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2017
    Review
  19. Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2017
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Greisa VilaDepartment of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria.
Gabriele Grimm
Michael Resl
Birgit Heinisch
Elisa Einwallner
Harald Esterbauer
Benjamin Dieplinger
Thomas Mueller
Anton Luger
Martin Clodi
Medical University of Vienna · ATConvent Hospital of the Brothers of Saint John of God · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic heart failure is accompanied by anorexia and increased release of B-type natriuretic peptide (BNP) from ventricular cardiomyocytes. The pathophysiological mechanisms linking heart failure and appetite regulation remain unknown. In this study, we investigated the impact of intravenous BNP administration on appetite-regulating hormones and subjective ratings of hunger and satiety in 10 healthy volunteers. Participants received in a randomized, placebo-controlled, crossover, single-blinded study (subject) placebo once and 3.0 pmol/kg/min human BNP-32 once administered as a continuous infusion during 4 h. Circulating concentrations of appetite-regulating peptides were measured hourly. Subjective ratings of hunger and satiety were evaluated by visual analog scales. BNP inhibited the fasting-induced increase in total and acylated ghrelin concentrations over time (P = 0.043 and P = 0.038, respectively). In addition, BNP decreased the subjective rating of hunger (P = 0.009) and increased the feeling of satiety (P = 0.012) when compared with placebo. There were no significant changes in circulating peptide YY, glucagon-like peptide 1, oxyntomodulin, pancreatic polypeptide, leptin, and adiponectin concentrations. In summary, our results demonstrate that BNP exerts anorectic effects and reduces ghrelin concentrations in men. These data, taken together with the known cardiovascular properties of ghrelin, support the existence of a heart-gut-brain axis, which could be therapeutically targeted in patients with heart failure and obesity.

Indexed as

AcylationAdultBlood GlucoseCross-Over StudiesGhrelinHumansHungerInsulinLeptinMaleNatriuretic Peptide, BrainPeptide YYSatiationSingle-Blind MethodBlood GlucoseGhrelinInsulinLeptinNatriuretic Peptide, BrainPeptide YY

Identifiers

PMID22698919
PMCPMC3447894
OpenAlexW2121327586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.